⌕
Natera · NTRA · Nasdaq
Tenet 44 · Weak
Compare
$319.09−1.19%At closeTenet 44 · Weak
$319.09−3.85 (−1.19%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD
$318.60−0.49 (−0.15%)
After hours: Nov 13, 2026, 5:56 PM ET

Natera (NTRA) Stock

Natera (NTRA) closed at $319.09 on Nov 13, 2026; its Tenet Score is 44 of 100 against 409 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

15 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$319.09
Nov 13, 2026
Market cap
$46.3B
share price × the latest quarter's diluted weighted-average share count (vendor)
52-week range
181.00 – 437.41
low → high
Tenet Score
44/100
Weak · 409 Healthcare peers

Industry: Health Services · see every company filed here →

Natera Inc scores 44/100. Weak. Strongest on growth, value is the soft spot versus 409 Healthcare peers.

Tenet Score · vs sector

n=409
44/ 100
Weak
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
4
Quality
52
Health
53
Growth
69

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueFQualityCHealthCGrowthCMomentumA
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
24.7×
price to book value
P/S
15.9×
price to fiscal 2025 sales
ROE
−11%
return on equity
Operating margin
−13.4%
fiscal 2025, before interest and tax
Net margin
−5.7%
of revenue kept
Current ratio
2.81
current assets to liabilities
Net debt / EBITDA
—
Not meaningful: EBITDA is zero or negative.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Natera Inc

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=409) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 242 US ETFs · top wrappers by weightSee all ETFs holding NTRA →

Similar-sized companies in Health Services

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

Compare Natera with

What sector and industry is Natera in?

Natera is in the Healthcare sector and the Health Services industry.

What is Natera's Tenet Score?

Natera's Tenet Score is 44 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.